Salivary Gland Cancer
📧 Sign up to get email alerts when something new happens for Salivary Gland Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-12-29Clinical Trial Update: Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Cancers [Phase 1, Phase 2]
Phase 1/2 trial evaluating nivolumab and ipilimumab with stereotactic body radiation therapy in salivary gland cancers; study status complet…
-
CLINICAL_TRIALS trial_result · 2023-10-19Clinical Trial Update: Activity of Sorafenib in Salivary Gland Cancer [Phase 2]
Phase 2 clinical trial update on sorafenib in salivary gland cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene [Phase 1, Phase 2]
Phase 1/2 clinical trial studying A166 in patients with various HER2-expressing or HER2-amplified cancers has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer Patients [Phase 2]
Phase 2 clinical trial evaluating Lutetium-177-PSMA radioligand therapy for advanced salivary gland cancers has completed.
-
CLINICAL_TRIALS trial_result · 2021-08-17Clinical Trial Update: Weekly Docetaxel Plus Cisplatin as First-line Chemotherapy in Metastatic Salivary Gland Cancer Patients : a Multicenter Phase II Study [Phase 2]
A multicenter Phase II study evaluating weekly docetaxel plus cisplatin as first-line chemotherapy in metastatic salivary gland cancer is un…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: Surufatinib in Recurrent/Metastatic Head and Neck Adenocarcinomas [Phase 2]
Phase 2 clinical trial update for Surufatinib in recurrent/metastatic head and neck adenocarcinomas (salivary gland origin) with unknown sta…
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: Abiraterone Acetate in Patients With Relapsed and/or Metastatic Salivary Gland Cancers [Phase 2]
Phase 2 trial update of abiraterone acetate in relapsed/metastatic salivary gland cancers completed.
-
CLINICAL_TRIALS trial_result · 2020-04-10Clinical Trial Update: Stereotactic Body Radiotherapy for Head and Neck Tumors [Phase 4]
Phase 4 clinical trial update on stereotactic body radiotherapy for head and neck tumors with completed status and posted results in 2020.
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers [Phase 2]
Phase 2 trial results of enzalutamide in patients with androgen receptor–positive salivary gland cancer have been posted.
-
CLINICAL_TRIALS trial_result · 2019-08-30Clinical Trial Update: Axitinib in R/M Salivary Gland Cancers of the Upper Aerodigestive Tract - SGC-AX14 [Phase 2]
Phase 2 trial update of axitinib in relapsed/refractory salivary gland cancers of the upper aerodigestive tract has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Imatinib Mesylate in Treating Patients With Salivary Gland Cancer [Phase 2]
Phase 2 trial update of Imatinib Mesylate for salivary gland cancer (a form of head and neck cancer) has been completed.
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Eribulin Mesylate in Treating Patients With Recurrent or Metastatic Salivary Gland Cancer [Phase 2]
Phase 2 clinical trial evaluating eribulin mesylate in recurrent or metastatic salivary gland cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-11-24Clinical Trial Update: Iressa Study in Patients With Salivary Gland Cancer [Phase 2]
Phase 2 trial of Iressa (gefitinib) in salivary gland cancer has completed enrollment with results posted.
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer [Phase 2]
This clinical trial update summarizes a Phase 2 study of trastuzumab in patients with advanced salivary gland cancer, which has completed en…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]
Phase 2 clinical trial update for SB-715992 in patients with recurrent or metastatic head and neck cancer; the study completed and results w…
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Title XELOX FOR SALIVARY GLAND CANCERS [Phase 2]
Phase 2 study of the XELOX regimen (capecitabine plus oxaliplatin) for salivary gland cancers and head and neck cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery [Phase 2]
Phase 2 trial of gemcitabine for advanced, unresectable salivary gland cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-13Clinical Trial Update: Study of I-125 Brachytherapy Versus Intensity-modulated Radiation Therapy to Treat Inoperable Salivary Gland Cancer [Phase 3]
Phase 3 clinical trial comparing I-125 brachytherapy to intensity-modulated radiation therapy for inoperable salivary gland cancer; the curr…
-
CLINICAL_TRIALS withdrawal · 2016-05-23Clinical Trial Update: Postoperative Radiotherapy and Panitumumab in High-Risk Salivary Gland Malignancies [Phase 2]
A Phase 2 trial evaluating postoperative radiotherapy combined with panitumumab for high-risk salivary gland cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors [Phase 2]
A randomized Phase II trial compared adjuvant concurrent radiation and chemotherapy versus radiation alone after surgical resection of high-…
-
CLINICAL_TRIALS research · 2015-11-20Clinical Trial Update: Trial of BIBF1120 (Nintedanib) in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck [Phase 2]
A Phase 2 clinical trial evaluating nintedanib (BIBF1120) in patients with recurrent or metastatic salivary gland cancer of the head and nec…
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating OPB-111001 in multiple advanced cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-09-01Clinical Trial Update: Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab [Phase 2]
This Phase II randomized trial assessed cetuximab with sorafenib versus cetuximab alone in metastatic head and neck squamous cell carcinomas…
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands [Phase 2]
This entry reports the completion of a Phase 2 trial evaluating sunitinib for recurrent and/or metastatic adenoid cystic carcinoma of the sa…
-
CLINICAL_TRIALS trial_result · 2015-06-26Clinical Trial Update: Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma [Phase 2]
Phase 2 clinical trial evaluating the Akt inhibitor MK2206 in patients with progressive, recurrent, or metastatic adenoid cystic carcinoma o…